Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/CUP stock hub

FRA/CUP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/CUPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

70.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/CUP

In the news

Latest news · FRA/CUP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E28.6

P25 n/aP50 n/aP75 n/a

ROE23.7

P25 n/aP50 n/aP75 n/a

ROIC41.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/CUP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

JPY

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Japan
Country code	DE
Employees	5,104
Employees Change	2,846%
Employees Change Percent	56.63
Enterprise value	EUR 65.9B
Exchange	Frankfurt Stock Exchange
Financial currency	JPY
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 70.5B
Price	EUR 42.35
Price currency	EUR
Rev Per Employee	1,379,911.18x
Sic	2834
Symbol	fra/CUP
Website	https://www.chugai-pharm.co.jp

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.5%
EV Earnings	26.72x
EV/EBIT	19.85x
EV/EBITDA	18.84x
EV/FCF	32.25x
EV/Sales	9.41x
FCF yield	2.9%
P/B ratio	6.78x
P/E ratio	28.59x
P/S ratio	10.01x
PE Ratio10 Y	31.36x
PE Ratio3 Y	27.74x
PE Ratio5 Y	24.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.42%
EBITDA Margin	49.48%
FCF margin	29.02%
Gross margin	71.45%
Gross Profit	EUR 5B
Gross Profit Growth	6.31%
Gross Profit Growth Q	14.12%
Gross Profit Growth3 Y	9.72%
Gross Profit Growth5 Y	12.64%
Net Income	EUR 2.5B
Net Income Growth	10.25%
Net Income Growth Q	18.7%
Net Income Growth3 Y	12.67%
Net Income Growth5 Y	16.51%
Pretax Margin	48.18%
Profit Margin	35.02%
Profit Per Employee	EUR 483,253
ROA	17.38
Roa5y	17.07
ROCE	31.6
ROE	23.71
Roe5y	24.4
ROIC	41.79
Roic5y	42.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	17.83%
Cagr15y	19.81%
Cagr1y	-15.12%
Cagr3y	23.5%
Cagr5y	8.92%
Div CAGR10	26.76%
Div CAGR3	41.25%
Div CAGR5	12.3%
EPS Growth	10.25
EPS Growth Q	18.7
EPS Growth3 Y	12.66
EPS Growth5 Y	16.5
FCF Growth	6.23%
FCF Growth Q	145.3%
FCF Growth3 Y	15.44%
FCF Growth5 Y	16.9%
OCF Growth	6.84%
OCF Growth Q	83.03%
OCF Growth10 Y	24.36%
OCF Growth3 Y	13.84%
OCF Growth5 Y	12.36%
Revenue Growth	5.66x
Revenue Growth Q	11.54x
Revenue Growth3 Y	2.14x
Revenue Growth5 Y	10.71x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.59
Assets	EUR 12.4B
Cash	EUR 4.6B
Current Assets	EUR 8.3B
Current Liabilities	EUR 1.8B
Equity	EUR 10.4B
Interest Coverage	2,957.7
Liabilities	EUR 1.9B
Long Term Assets	EUR 4B
Long Term Liabilities	EUR 175.7M
Net Cash	EUR 4.6B
Net Cash By Market Cap	EUR 6.57
Net Cash Growth	-10%
Net Debt EBITDA	EUR -1.33
Net Debt Equity	EUR -0.45
Net Debt FCF	EUR -2.27
Tangible Book Value	EUR 10.1B
Tangible Book Value Per Share	EUR 6.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.7
Inventory Turnover	1.41
Net Working Capital	EUR 2B
Quick ratio	3.67
Working Capital	EUR 6.6B
Working Capital Turnover	EUR 0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%
Dividend Growth	162.64%
Dividend Growth Years	2%
Dividend per share	EUR 1.54
Dividend Years	27
Dividend Yield	3.63%
Ex Div Date	2025-12-29
Last Dividend	EUR 0.8
Payout Frequency	Semi-Annual
Payout Ratio	99.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	415.61%
1Y total return	-15.11%
200-day SMA	43.77
3Y total return	88.38%
50-day SMA	47.76
50-day SMA vs 200-day SMA	50over200
5Y total return	53.31%
All Time High	56.26
All Time High Change	-24.72%
All Time High Date	2026-02-27
All Time Low	3.54
All Time Low Change	1,096.33%
All Time Low Date	2011-11-04
ATR	1.62
Ch YTD	-4.38
High	42.61
High52	56.26
High52 Date	2026-02-27
High52ch	-24.72%
Low	42.17
Low52	33.02
Low52 Date	2025-08-07
Low52ch	28.26%
Ma50ch	-11.33%
Price vs 200-day SMA	-3.24%
RSI	41.59
RSI Monthly	50.76
RSI Weekly	43.98
Sharpe ratio	-0.1x
Sortino ratio	-0.02
Total Return	3.63%
Tr YTD	-4.38
Tr15y	1,404.23%
Tr1m	-10.62%
Tr1w	-4.66%
Tr3m	-9.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.3B
Operating Income Growth	5.78
Operating Income Growth Q	16.18
Operating Income Growth3 Y	11.25
Operating Income Growth5 Y	15.9
Operating margin	47.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	639,882,056%
Net Borrowing	-46,845,876.4
Shares Insiders	0.01%
Shares Institutions	19.04%
Shares Qo Q	0%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 2B
Average Volume	12.55x
Bv Per Share	6.32
CAPEX	EUR -364.7M
Ch10y	332.9
Ch15y	1,031.7
Ch1m	-10.62
Ch1w	-4.66
Ch1y	-17.8
Ch3m	-9.06
Ch3y	76.46
Ch5y	37.68
Ch6m	2.25
Change	-3.31%
Change From Open	-0.61
Close	43.8
Days Gap	-2.72
Depreciation Amortization	144,169,470.2
Earnings Date	2026-04-24
EBIT	EUR 3.3B
EBITDA	EUR 3.5B
EPS	EUR 1.5
F Score	4
FCF	EUR 2B
FCF EV Yield	3.1x
Financing CF	-2,493,228,883
Fiscal Year End	December
Founded	1,925
Graham Number	14.42966
Graham Upside	-65.93
Income Tax	EUR 927.2M
Investing CF	-3,223,636
Is Primary Listing	0
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2020-06-29
Last Split Type	Forward
Lynch Fair Value	EUR 24.45
Lynch Upside	-42.26
Ma150	45.61
Ma150ch	-7.14%
Ma20	44.91
Ma20ch	-5.7%
Net CF	-29,645,452
Next Earnings Date	2026-07-24
Open	42.61
P FCF Ratio	34.5
P OCF Ratio	29.28
Payment Date	2026-03-27
Position In Range	40.91
Ppne	2,607,125,928.6
Price Date	2026-05-08
Price EBITDA	EUR 20.24
Ptbv Ratio	6.99
Relative Volume	4.49x
Revenue	7,043,066,686x
SBC By Revenue	0.04x
Share Based Comp	2,634,545
Tax By Revenue	13.16x
Tax Rate	27.32%
Tr6m	3.83%
Z Score	24.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/CUP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.6%

$1.54 annual per share

Payout ratio

+99.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.3%

2 consecutive years of growth

Total shareholder yield

+3.6%

Next ex-dividend date: 2025-12-29

Performance

FRA/CUP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/CUP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.0%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

FRA/CUP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-3.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/CUP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/CUP stock rating?

fra/CUP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/CUP analysis?

The full report lives at /stocks/fra/CUP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/CUP?

The latest report frames fra/CUP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/CUP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.